Business Context and Reporting Period
This Form 6-K filing by TNL Mediagene, a Cayman Islands exempted company, covers the period of November 2025. The report addresses a regulatory determination regarding the company's listing status on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory notice and does not contain financial statements or performance data.
Material Changes
On November 6, 2025, the company received a Determination Letter from Nasdaq stating it failed to regain compliance with Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share by November 3, 2025. Consequently, the company is not eligible for a second 180-day grace period.
Outlook, Risks, and Management Commentary
- Immediate Status: The Determination Letter has no immediate effect on the listing of the company's ordinary shares.
- Management Action: The company intends to timely request a hearing, which will automatically stay any suspension or delisting action pending the hearing.
- Potential Extension: The Nasdaq Hearing Panel has the authority to grant an extension not to exceed 180 days from the date of the Determination Letter.
- Risk: The primary risk is potential delisting if the company fails to regain compliance or secure an extension following the hearing process.
Investor Verification Checklist
- Verify the current trading price of TNL Mediagene shares to assess the severity of the bid price deficiency.
- Monitor for the filing of the hearing request and the scheduled date of the Nasdaq Hearing Panel review.
- Review the company's press release (Exhibit 99.1) for any additional details on capitalization plans or reverse stock split proposals.
- Check subsequent filings for the outcome of the hearing and any granted extensions.